{
    "title": "114_hr2391",
    "content": "The Act titled \"Medicaid Generic Drug Price Fairness Act of 2015\" applies the Medicaid additional rebate requirement to generic drugs. The Medicaid Generic Drug Price Fairness Act of 2015 applies an additional rebate requirement to generic drugs under Section 1927(c)(3) of the Social Security Act. The Medicaid Generic Drug Price Fairness Act of 2015 imposes increased rebates for single source or innovator multiple source drugs, following specific rules outlined in the legislation. The Medicaid Generic Drug Price Fairness Act of 2015 increases rebates for certain drugs, with adjustments to references and dates in the legislation. The Medicaid Generic Drug Price Fairness Act of 2015 adjusts references and dates in the legislation to determine the lowest average manufacturer price for a drug during a specific quarter. The Medicaid Generic Drug Price Fairness Act of 2015 adjusts references and dates in the legislation for determining the lowest average manufacturer price for a drug. References and dates are updated to reflect changes in subparagraphs and paragraphs. The Medicaid Generic Drug Price Fairness Act of 2015 updates references and dates in the legislation for determining the lowest average manufacturer price for drugs, including a special rule for certain noninnovator multiple source drugs. The Medicaid Generic Drug Price Fairness Act of 2015 updates references and dates for determining the lowest average manufacturer price for drugs, including a special rule for certain noninnovator multiple source drugs. The term 'applicable quarter' is defined as the fifth full calendar quarter for a specific drug. The Medicaid Generic Drug Price Fairness Act of 2015 updates references and dates for determining the lowest average manufacturer price for drugs, including a special rule for certain noninnovator multiple source drugs. The amendments made by subsection (a) shall apply to rebate periods beginning after December 31, 2014."
}